Regional and systemic serum concentrations of 5-fluorouracil after portal and intravenous infusion: an experimental study in dogs
- PMID: 529028
- DOI: 10.1007/BF01061213
Regional and systemic serum concentrations of 5-fluorouracil after portal and intravenous infusion: an experimental study in dogs
Abstract
The serum and urinary concentrations of 5-FU after continuous portal and jugular infusion have been followed by means of a highly sensitive microbiological assay method. Our data indicate that more than 90% of 5-FU was eliminated in the liver after continuous portal infusion of 0.625 mg x kg-1 x hr-1, corresponding to a dose of 15 mg x kg-1 x 24 hr-1. Negligible amounts of intact 5-FU were excreted into the bile, and the urinary excretion was only a few percent of the amount infused. The arterial concentration was on average tenfold higher during the continuous jugular infusion than after the continuous portal infusion, indicating that the route of administration has a pronounced effect on the disposition of 5-FU. Twenty-three percent of the jugular dose reached the liver; 77% was degraded by extrahepatic metabolism. Of these, degradation in the prehepatic splanchnic area accounted for 15%.
Similar articles
-
Inactivation of 5-fluorouracil by the liver during continuous regional and systemic infusion in pigs.Eur Surg Res. 1976;8(6):489-96. doi: 10.1159/000127895. Eur Surg Res. 1976. PMID: 1017433
-
Concentration of biologically active 5-fluorouracil in general circulation during continuous portal infusion in man: a preliminary report.Cancer Lett. 1975 Nov;1(2):113-7. doi: 10.1016/s0304-3835(75)95831-0. Cancer Lett. 1975. PMID: 1235061
-
Influence of the routes of continuous intrahepatic infusion of 5-fluorouracil on its pharmacokinetics.J Surg Oncol. 1989 Jul;41(3):187-93. doi: 10.1002/jso.2930410311. J Surg Oncol. 1989. PMID: 2747244
-
[Pharmacokinetic studies on continuous intraportal 5-fluorouracil infusion].Gan To Kagaku Ryoho. 1994 Sep;21(13):2121-3. Gan To Kagaku Ryoho. 1994. PMID: 7944418 Japanese.
-
Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in vivo 19F NMR study.Cancer Chemother Pharmacol. 1998;42(4):341-4. doi: 10.1007/s002800050827. Cancer Chemother Pharmacol. 1998. PMID: 9744781
Cited by
-
Effect of age on the disposition and tissue clearances of fluorinated pyrimidines in rats.Pharm Res. 1985 Nov;2(6):279-84. doi: 10.1023/A:1016389517202. Pharm Res. 1985. PMID: 24271124
-
Clinical applicability of current pharmacokinetic models: splanchnic elimination of 5-fluorouracil in cancer patients.J Pharmacokinet Biopharm. 1988 Jun;16(3):229-49. doi: 10.1007/BF01062135. J Pharmacokinet Biopharm. 1988. PMID: 3221324
-
Cardiopulmonary hemodynamics and pharmacokinetics after hepatic intraarterial infusion of 5-fluorouracil (5-FU). An experimental study in the pig.Cancer Chemother Pharmacol. 1988;22(3):251-5. doi: 10.1007/BF00273420. Cancer Chemother Pharmacol. 1988. PMID: 3409458